Therapeutic monoclonal antibodies are one of the fastest-growing classes of drugs, targeting many disease areas including cancer, autoimmune disorders, chronic inflammation and infectious disease.
Traditional antibody screening workflows can be labor-intensive, may not support high-throughput applications, don’t allow for direct antibody comparison and need large amounts of reagents.
Download this whitepaper to discover how high-throughput flow cytometry can provide quantitative data on:- Binding
- Antibody internalization
- Antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and T-cell activation
